Breaking News
July 17, 2018 - Long-term survival worse for black survivors of in-hospital cardiac arrest
July 17, 2018 - Stanford data analyst’s childhood inspires his research: A Q&A
July 17, 2018 - Preventability of hospital readmissions changes over time, study reveals
July 17, 2018 - Nursing notes can help predict if ICU patients will survive
July 17, 2018 - Okayama University research could improve prognosis of diabetic kidney disease
July 17, 2018 - Study identifies new genes linked to heart function and development
July 17, 2018 - NeuroTrauma Sciences and Henry Ford join hands to advance exosome technology
July 17, 2018 - Improved methods to measure enterococci concentrations in recreational water
July 17, 2018 - White adolescent boys experiencing early puberty have high risk for substance use
July 17, 2018 - Celgene and Acceleron Announce Luspatercept Achieved Primary and All Key Secondary Endpoints in Phase III ‘BELIEVE’ Study in Adults with Transfusion-Dependent Beta-Thalassemia
July 17, 2018 - Roots of leukemia reveal possibility of predicting people at risk
July 17, 2018 - Summer med program embraces low-income students’ potential
July 17, 2018 - New research lays foundation to create standards for RNA sequencing
July 17, 2018 - CRISPR/Cas9 gene editing can cause greater genetic damage than previously thought
July 17, 2018 - Democrats rally against threats to the ACA to block Trump’s Supreme Court nominee
July 17, 2018 - Staggering prices slow insurers’ coverage of CAR-T cancer therapy
July 17, 2018 - How proteins involved in neurodegeneration enter cells
July 17, 2018 - New super-resolution ‘nanoscope’ provides insight into progression of Alzheimer’s disease
July 17, 2018 - FDA Advisory Committee Endorses the Effectiveness and Safety of Single-Dose Tafenoquine for the Radical Cure of P. vivax Malaria
July 17, 2018 - Uncovering the evolutionary history of IBD-associated colorectal cancer
July 17, 2018 - Is nutrition research dependable? Stanford’s John Ioannidis weighs in
July 17, 2018 - New machine learning framework predicts effects of genetic mutations in ‘dark matter’ regions
July 17, 2018 - Plant-based products fail to have positive impact on blood pressure during clinical studies
July 17, 2018 - Electronic system to speed up facial pain diagnosis may improve quality of life and save money
July 17, 2018 - Study delves into the role played by Protein Kinase C in synaptic plasticity
July 17, 2018 - Women Often Unaware of Their Hospital’s Religious Affiliation
July 17, 2018 - New AASM guideline recommends use of actigraphy for sleep disorders
July 17, 2018 - CRISPR editing reduces repetitive behavior in mice with a form of autism
July 17, 2018 - Scientists use magnets to detect cancer
July 17, 2018 - Microfluidic chip to detect sepsis proves successful in clinical study
July 17, 2018 - Research provides better understanding of mechanisms underlying memory storage
July 17, 2018 - A Multi-Modal Approach for the Early Detection of Breast Cancer
July 17, 2018 - Mailing colorectal cancer tests to patients increases screening rates, report researchers
July 17, 2018 - Scientists find possible sources of medicinal and antimicrobial drugs
July 17, 2018 - Molecules formed when the body metabolizes omega-3 fatty acids may inhibit cancer
July 17, 2018 - Efficient communication between hospitals improves patient safety and reduces mortality
July 17, 2018 - Study highlights potential of fetal gene therapy to prevent lethal neurodegenerative disease
July 17, 2018 - For Americans, in Science They Trust
July 17, 2018 - Combating HIV/AIDS | NIH MedlinePlus the Magazine
July 17, 2018 - Study shows minorities widely underrepresented in autism diagnoses
July 17, 2018 - Multigene testing replacing BRCA tests for breast cancer risk | News Center
July 17, 2018 - Pre-clinical pilot study shows promising results of ‘concussion pill’
July 17, 2018 - Researchers reduce size of tumors in mice by artificially activating the brain’s reward system
July 17, 2018 - New study documents symptoms of people before they acquire multiple sclerosis
July 17, 2018 - Researchers discover why CRISPR gene editing sometimes fails
July 17, 2018 - New finding may hold key to better understand the complexities of neurological disorders
July 17, 2018 - The Current issue of “The view from here” is concerned with Novel Targets.
July 17, 2018 - Fighting the Flu with a Universal Vaccine
July 17, 2018 - Key social reward circuit in the brain impaired in kids with autism | News Center
July 17, 2018 - Insight into causes, types and treatment of aphasia
July 16, 2018 - Quark Pharmaceuticals, Inc Announces First Patient Dosed in Phase 3 Clinical Trial of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
July 16, 2018 - NSAIDs shown to have causal role in cardiovascular risk of patients with osteoarthritis
July 16, 2018 - PET scan tracer predicts success of cancer ‘vaccine’ | News Center
July 16, 2018 - Parents struggle with what to do when their child has headache, shows study
July 16, 2018 - Outrageous or overblown? HHS announces another round of ACA navigator funding cuts
July 16, 2018 - Weight loss surgery may impact individual’s risk of developing cancer, shows study
July 16, 2018 - Alexion Submits Application for Priority Review and Approval of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) in the U.S.
July 16, 2018 - Restoring epigenetic balance reinstates memory in flies with Alzheimer’s disease symptoms
July 16, 2018 - Magnetized wire could be used to detect cancer in people | News Center
July 16, 2018 - Non-surgical management found to be feasible option for penetrating kidney trauma
July 16, 2018 - California clinic screens asylum seekers for honesty
July 16, 2018 - FDA Approves Xtandi (enzalutamide) for the Treatment of Men with Non-Metastatic Castration-Resistant Prostate Cancer (CRPC)
July 16, 2018 - Can nanotechnology help treat Alzheimer’s?
July 16, 2018 - Researchers identify protein essential for making stem cells | News Center
July 16, 2018 - Severe childhood infections linked with lower school achievement in adolescence
July 16, 2018 - Radiologist discusses causes, treatments of varicose veins
July 16, 2018 - Researchers develop nanostructured surface to accelerate wound healing after dental implants
July 16, 2018 - New non-invasive procedure to reposition kidney stones could benefit astronauts
July 16, 2018 - Attending Surgeon Influences Genetic Testing in Breast Cancer
July 16, 2018 - Medical doctors with addictions fear professional repercussions if they seek treatment
July 16, 2018 - 5 Questions: John Ioannidis calls for more rigorous nutrition research | News Center
July 16, 2018 - University of Illinois buys 3D-Bioplotter for regenerative biology, tissue engineering research
July 16, 2018 - Charité’s researchers integrate open-source platform into the ‘Human Brain Project’
July 16, 2018 - SUSU scientists develop rehabilitation device for people with lower limbs injuries
July 16, 2018 - Researchers find definite increase in scooter-related injuries
July 16, 2018 - Researchers solve mystery of final blood group system
July 16, 2018 - Researchers develop near-infrared fluorophores-based PDT to cure cancer with less side effects
July 16, 2018 - Traumatic brain injury biomarker could help predict patient prognosis
July 16, 2018 - Researchers to investigate role of hormones in mosquito’s ability to use human blood for egg production
July 16, 2018 - AHA: Doctor Makes Lifesaving House Call in His Own Home
T1D with Eye Disorder, CKD Tied to Heart Complications

T1D with Eye Disorder, CKD Tied to Heart Complications

image_pdfDownload PDFimage_print

Action Points

  • Chronic kidney disease (CKD) and proliferative diabetic retinopathy (PDR) in people with type 1 diabetes may be tied to microvascular complications.
  • Note that PDR was also independently tied to cardiovascular disease among patients with type 1 diabetes and CKD, while CKD without PDR was not tied to cardiovascular disease risk.

Chronic kidney disease and proliferative diabetic retinopathy in people with type 1 diabetes may be tied to microvascular complications, researchers reported.

Among older patients with type 1 diabetes, cardiovascular disease prevalence was 68.2% among those with both chronic kidney disease (CKD) and proliferative diabetic retinopathy (PDR). This was significantly higher compared to patients who only had CKD (34.5%) or PDR (42.8%) (P=0.002), according to Daniel Gordin, MD, PhD, of Joslin Diabetes Center in Boston, and colleagues.

The lowest prevalence of cardiovascular disease was seen in patients without either CKD or PDR (28.8%), they wrote in Diabetes Care.

However, PDR was also independently tied to cardiovascular disease among patients with type 1 diabetes and CKD (OR 0.21, 95% CI 0.08-0.58, P=0.003), while CKD without PDR was not tied to cardiovascular disease risk.

“The co-occurrence of CKD and PDR is not surprising since chronic hyperglycemia is the major contributor to diabetic microvascular complications,” the group wrote.

However, “these unexpected findings suggest that PDR adds to the toxicity of chronic kidney disease in the development of cardiovascular disease, or that there could be a common protective factor against hyperglycemic toxicity for severe diabetic eye disease and CVD,” they added.

A total of 762 individuals who participated in the Joslin Medalist Study were included in the current cross-sectional analysis. All participants had type 1 diabetes with insulin treatment for 50 years or more.

Estimated glomerular filtration rate was determined using the Chronic Kidney Disease Epidemiology Collaboration formula, while CKD was defined as stage 3b CKD (eGFR <45 mL/min/1.73m2). PDR was determined using the Early Treatment Diabetic Retinopathy Study (ETDRS) protocol, defined as a score of over 53.

Among the cohort, the majority of individuals did not have CKD but did have PDR (n=339). The second largest group included those without CKD and PDR (n=327), while there were 66 individuals with both conditions. Although all groups had no significant differences in HbA1c levels, those with CKD and without PDR were notably older at the time of type 1 diabetes diagnosis. This group also had the highest prevalence of random detectable C-peptide versus all other groups.

A secondary analysis was also performed by the group, which included 675 individuals with type 1 diabetes for 25 years or more from the FinnDiane Study. This study utilized the same definition for CKD, while PDR was defined as a score of 60 or greater on the ETDRS scale.

This analysis found similar trends as the Medalist cohort, with a trend towards a lower prevalence of cardiovascular disease seen among the group with CKD but without PDR (19.1%) versus those with both conditions (37.1%, P=0.10). The group noted this relationship likely didn’t reach significance “due to small sample size and number of events.”

Similar to the Medalist study, the lowest prevalence of cardiovascular disease was seen in the group without either CKD or PDR (6.6%).

“Multiple possible factors could be involved in this differential protection on the retinal, renal and cardiovascular tissue in diabetes,” the authors suggested. “Of particular interest could be insulin and vascular endothelial growth factor (VEGF), which have been targets of therapeutic modulations for all three complications.”

“Interestingly, VEGF expressions are elevated in the retina and renal glomeruli, yet decreased by diabetes in the myocardium. This differential tissue expression of VEGF in diabetes made systemic treatments targeting VEGF difficult, but may provide an explanation for differential contributions to CKD, PDR, and neuropathy in addition to CVD.”

Study limitations included the long duration of type 1 diabetes in patients from both cohorts. The authors suggested future studies include patients with a shorter duration of diabetes aimed at determining whether CKD with PDR “is a marker of more generalized vascular dysfunction or whether tissue specific protective factors are in play.”

Click here for the American Association of Clinical Endocrinologists’ clinical practice guidelines for developing a diabetes mellitus comprehensive care plan.

The study was supported by the Iacocca Foundation, the Folkhälsan Research Foundation, the Wilhelm and Else Stockmann Foundation, the Livoch Hälsa Foundation, The Medical Society of Finland (Finska Läkaresällskapet), the Finnish Medical Foundation, The Swedish Cultural Foundation in Finland, the Biomedicum Helsinki Foundation, the Dorothea Olivia, Karl Walter och Jarl Walter Perkléns Foundation, Academy of Finland, Novo Nordisk Foundation, Päivikki and Sakari Sohlberg Foundation, and by EVO governmental grants.

Gordin disclosed no relevant relationships with industry. One co-author disclosed relevant relationships with Eli Lilly, Roche, AbbVie, Astra Zeneca, Boehringer Ingelheim, Eli Lilly, Janssen, Medscape, MSD, Novartis, and Sanofi, Genzyme, Novartis, Novo Nordisk, and Sanofi.

  • Reviewed by
    Robert Jasmer, MD Associate Clinical Professor of Medicine, University of California, San Francisco and Dorothy Caputo, MA, BSN, RN, Nurse Planner

2018-01-02T00:00:00-0500

last updated

Tagged with:

About author

Related Articles